Ampersand Biosciences LLC
Lake Clear, NY
- UEI
- HLWQXLFM7JR8
- CAGE
- 79VC0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6459 NY-30, Lake Clear, NY 12945, USA
- Website
- ampersandbio.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Definitive Contract 75N93025C00018 | National Institute of Allergy and Infectious Diseases | $599,987 | |
| Definitive Contract 75N93024C00087 | National Institute of Allergy and Infectious Diseases | $1,084,824 | |
| Sbir topic 107 reagents for immunologic analysis of non- mammalian and underrepresented mammalian models | National Institute of Allergy and Infectious Diseases | $596,519 | |
| Development of ferret reagents for use in the characterization of immune responses to respiratory infections in the… | National Institute of Allergy and Infectious Diseases | $572,817 | |
| Ampersand BIO map analysis | CDC Pittsburgh | $20,000 |
About Ampersand Biosciences LLC
Ampersand Biosciences LLC is a woman-owned small business biotechnology research company located in Lake Clear, New York, specializing in immunological research and development of advanced scientific reagents. Registered in SAM.gov since December 2014 with active registration until April 2026, the company operates as a limited liability partnership and focuses on developing innovative solutions for understanding and potentially preventing infectious diseases. The firm has established itself as a focused research entity with expertise in immunological studies, particularly in respiratory disease models.
The company has secured multiple federal contract awards from the National Institute of Allergy and Infectious Diseases (NIAID), totaling approximately $2.28 million across three recent contracts. These contracts consistently center on developing monoclonal antibodies and immunological research reagents, with specific focus on respiratory disease models involving non-traditional research subjects like ferrets and mice. The contract awards, ranging from $596,519 to $1,084,824, have supported projects such as developing monoclonal antibodies to chemokines, characterizing and validating antibodies for respiratory disease research, and creating reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models. None of these contracts were set-aside, and they all represent definitive, firm fixed-price agreements with completion dates ranging from December 2024 to May 2027, demonstrating Ampersand Biosciences' ongoing commitment to advanced infectious disease research.
Quick answers
What is Ampersand Biosciences LLC's UEI?
Ampersand Biosciences LLC's Unique Entity ID (UEI) in SAM.gov is HLWQXLFM7JR8.
What is Ampersand Biosciences LLC's CAGE code?
Ampersand Biosciences LLC's CAGE code is 79VC0.
What is Ampersand Biosciences LLC's primary NAICS code?
Ampersand Biosciences LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Ampersand Biosciences LLC located?
Ampersand Biosciences LLC's physical address in SAM.gov is 6459 NY-30, Lake Clear, NY 12945, USA.
Is Ampersand Biosciences LLC registered in SAM.gov?
Yes. Ampersand Biosciences LLC's SAM.gov registration is active through February 17, 2027.
What is Ampersand Biosciences LLC's most recent federal award?
Ampersand Biosciences LLC's most recent federal contract award is Definitive Contract 75N93025C00018 (75N93025C00018), from National Institute of Allergy and Infectious Diseases, on June 1, 2025.
On GovTribe
See Ampersand Biosciences LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors